UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Quality assurance for prospective EORTC radiation oncology trials: The challenges of advanced technology in a multicenter international setting

Radiotherapy and oncology, 2011-07, Vol.100 (1), p.150-156

2011

Volltextzugriff (PDF)

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma

The New England journal of medicine, 2015-12, Vol.373 (26), p.2499-2511

2015

Volltextzugriff (PDF)

Over-irradiation

Breast (Edinburgh), 2017-02, Vol.31, p.295-302

2017

Volltextzugriff (PDF)

Duration of Androgen Suppression in the Treatment of Prostate Cancer

The New England journal of medicine, 2009-06, Vol.360 (24), p.2516-2527

2009

Volltextzugriff (PDF)

Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991

Journal of clinical oncology, 2016-05, Vol.34 (15), p.1748-1756

2016

Volltextzugriff (PDF)

Winter is over: The use of Artificial Intelligence to individualise radiation therapy for breast cancer

Breast (Edinburgh), 2020-02, Vol.49, p.194-200

2020

Volltextzugriff (PDF)

Ten-year conditional recurrence risks and overall and relative survival for breast cancer patients in the Netherlands: Taking account of event-free years

European journal of cancer (1990), 2018-10, Vol.102, p.82-94

2018

Volltextzugriff (PDF)

Surgery and radiation therapy of triple-negative breast cancers: From biology to clinics

Breast (Edinburgh), 2016-08, Vol.28, p.148-155

2016

Volltextzugriff (PDF)

High-Dose Methotrexate-Based Chemotherapy Followed by Consolidating Radiotherapy in Non–AIDS-Related Primary Central Nervous System Lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962

Journal of clinical oncology, 2003-12, Vol.21 (24), p.4483-4488

2003

Volltextzugriff (PDF)

Reduction of the treated volume to involved node radiation therapy as part of combined modality treatment for early stage aggressive non-Hodgkin’s lymphoma

Radiotherapy and oncology, 2013-10, Vol.109 (1), p.133-139

2013

Volltextzugriff (PDF)

Infiltrating lobular breast cancer: Truly a separate entity! Consequences for radiation therapy

Radiotherapy and oncology, 2013, Vol.106 (1), p.1-4

2013

Volltextzugriff (PDF)

Outcome after combined modality treatment for uterine papillary serous carcinoma: A study by the Rare Cancer Network (RCN)

Gynecologic oncology, 2008-02, Vol.108 (2), p.298-305

2008

Volltextzugriff (PDF)

Patient Positioning Based on a Radioactive Tracer Implanted in Patients With Localized Prostate Cancer: A Performance and Safety Evaluation

International journal of radiation oncology, biology, physics, 2013-02, Vol.85 (2), p.555-560

2013

Volltextzugriff (PDF)

Ten‐year recurrence rates for breast cancer subtypes in the Netherlands: A large population‐based study

International journal of cancer, 2019-01, Vol.144 (2), p.263-272

2019

Volltextzugriff (PDF)

Breast conserving therapy and mastectomy revisited: Breast cancer‐specific survival and the influence of prognostic factors in 129,692 patients

International journal of cancer, 2018-01, Vol.142 (1), p.165-175

2018

Volltextzugriff (PDF)

Population-Based Study of Trends and Variations in Radiotherapy as Part of Primary Treatment of Cancer in the Southern Netherlands Between 1988 and 2006, With an Emphasis on Breast and Rectal Cancer

International journal of radiation oncology, biology, physics, 2009-06, Vol.74 (2), p.464-471

2009

Volltextzugriff (PDF)

Increased risk for second primary rectal cancer after pelvic radiation therapy

European journal of cancer (1990), 2020-01, Vol.124, p.142-151

2020

Volltextzugriff (PDF)

De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03): 5-year follow-up results of a Dutch, prospective, registry study

The lancet oncology, 2022-09, Vol.23 (9), p.1201-1210

2022

Volltextzugriff (PDF)

Between Uncertainties and Overtreatment

International journal of radiation oncology, biology, physics, 2019-05, Vol.104 (1), p.15-16

2019

Volltextzugriff (PDF)

Is Postoperative Breast Radiation Therapy Safe in Patients With Scleroderma?

International journal of radiation oncology, biology, physics, 2019-05, Vol.104 (1), p.10-11

2019

Volltextzugriff (PDF)

Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 – EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures

Journal of geriatric oncology, 2021-03, Vol.12 (2), p.182-189

2021

Volltextzugriff (PDF)

Radiotherapy preserves fingers in the management of subungual squamous cell carcinoma, obviating the need for amputation

Radiotherapy and oncology, 2007-12, Vol.85 (3), p.473-476

2007

Volltextzugriff (PDF)

The 2016 Assisi Think Tank Meeting on breast cancer: white paper

Breast cancer research and treatment, 2016-11, Vol.160 (2), p.211-221

2016

Volltextzugriff (PDF)

The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: a quality-assurance report on the dummy run of EORTC Phase III randomized trial 22922/10925 in Stage I–III breast cancer

International journal of radiation oncology, biology, physics, 2001-04, Vol.49 (5), p.1399-1408

2001

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(47)
Buchkapitel
(1)

Sprache

Englisch
(48)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(40)
Science & Technology
(40)
Oncology
(34)
Humans
(31)
Female
(21)
Breast Cancer
(18)
Middle Aged
(14)
Radiation Therapy
(14)
Adult
(13)
Male
(12)
Mastectomy
(12)
Radiology, Nuclear Medicine & Medical Imaging
(12)
Radiotherapy
(12)
Aged
(11)
Combined Modality Therapy
(11)
Hematology, Oncology And Palliative Medicine
(11)
Patients
(11)
Cancer
(9)
Breast Neoplasms - Radiotherapy
(8)
Chemotherapy
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Quality assurance for prospective EORTC radiation oncology trials: The challenges of advanced technology in a multicenter international setting

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma

Over-irradiation

Duration of Androgen Suppression in the Treatment of Prostate Cancer

Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991

Winter is over: The use of Artificial Intelligence to individualise radiation therapy for breast cancer

Ten-year conditional recurrence risks and overall and relative survival for breast cancer patients in the Netherlands: Taking account of event-free years

Surgery and radiation therapy of triple-negative breast cancers: From biology to clinics

High-Dose Methotrexate-Based Chemotherapy Followed by Consolidating Radiotherapy in Non–AIDS-Related Primary Central Nervous System Lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962

Reduction of the treated volume to involved node radiation therapy as part of combined modality treatment for early stage aggressive non-Hodgkin’s lymphoma

Infiltrating lobular breast cancer: Truly a separate entity! Consequences for radiation therapy

Outcome after combined modality treatment for uterine papillary serous carcinoma: A study by the Rare Cancer Network (RCN)

Patient Positioning Based on a Radioactive Tracer Implanted in Patients With Localized Prostate Cancer: A Performance and Safety Evaluation

Ten‐year recurrence rates for breast cancer subtypes in the Netherlands: A large population‐based study

Breast conserving therapy and mastectomy revisited: Breast cancer‐specific survival and the influence of prognostic factors in 129,692 patients

Population-Based Study of Trends and Variations in Radiotherapy as Part of Primary Treatment of Cancer in the Southern Netherlands Between 1988 and 2006, With an Emphasis on Breast and Rectal Cancer

Increased risk for second primary rectal cancer after pelvic radiation therapy

De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03): 5-year follow-up results of a Dutch, prospective, registry study

Between Uncertainties and Overtreatment

Is Postoperative Breast Radiation Therapy Safe in Patients With Scleroderma?

Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 – EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures

Radiotherapy preserves fingers in the management of subungual squamous cell carcinoma, obviating the need for amputation

The 2016 Assisi Think Tank Meeting on breast cancer: white paper

The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: a quality-assurance report on the dummy run of EORTC Phase III randomized trial 22922/10925 in Stage I–III breast cancer

De-escalation of axillary treatment in the event of a positive sentinel lymph node biopsy in cT1–2 N0 breast cancer treated with mastectomy: nationwide registry study (BOOG 2013-07)

Suchergebnisse filtern